Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP865095.RAly6m6HuAx9Qk3ZOQYCM1q4rh_mCSaSMJD0a2gnijumE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP865095.RAly6m6HuAx9Qk3ZOQYCM1q4rh_mCSaSMJD0a2gnijumE130_assertion type Assertion NP865095.RAly6m6HuAx9Qk3ZOQYCM1q4rh_mCSaSMJD0a2gnijumE130_head.
- NP865095.RAly6m6HuAx9Qk3ZOQYCM1q4rh_mCSaSMJD0a2gnijumE130_assertion description "[The aim of the study was to evaluate the expression profile of MMP-2, MMP-9 and their tissue inhibitors TIMP-1 and TIMP-2 at the mRNA level in human colorectal cancer cell line Caco-2 treated with IP6.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP865095.RAly6m6HuAx9Qk3ZOQYCM1q4rh_mCSaSMJD0a2gnijumE130_provenance.
- NP865095.RAly6m6HuAx9Qk3ZOQYCM1q4rh_mCSaSMJD0a2gnijumE130_assertion evidence source_evidence_literature NP865095.RAly6m6HuAx9Qk3ZOQYCM1q4rh_mCSaSMJD0a2gnijumE130_provenance.
- NP865095.RAly6m6HuAx9Qk3ZOQYCM1q4rh_mCSaSMJD0a2gnijumE130_assertion SIO_000772 21229878 NP865095.RAly6m6HuAx9Qk3ZOQYCM1q4rh_mCSaSMJD0a2gnijumE130_provenance.
- NP865095.RAly6m6HuAx9Qk3ZOQYCM1q4rh_mCSaSMJD0a2gnijumE130_assertion wasDerivedFrom befree-2016 NP865095.RAly6m6HuAx9Qk3ZOQYCM1q4rh_mCSaSMJD0a2gnijumE130_provenance.
- NP865095.RAly6m6HuAx9Qk3ZOQYCM1q4rh_mCSaSMJD0a2gnijumE130_assertion wasGeneratedBy ECO_0000203 NP865095.RAly6m6HuAx9Qk3ZOQYCM1q4rh_mCSaSMJD0a2gnijumE130_provenance.